PROM1 and carcinoma: According to the gene expression profiling interactive analysis (GEPIA) database, the CD133 marker in CRC is prominently upregulated compared to para-carcinoma tissue, and is negatively correlated with disease-free survival and overall survival of CRC patients (Supplementary Figure S4), indicating that CD133 is a reliable carcinogenic factor in CRC.